SALIX PHARMACEUTICALS INC's ticker is SLXP and the CUSIP is 795435106. A total of 309 filers reported holding SALIX PHARMACEUTICALS INC in Q2 2014. The put-call ratio across all filers is 0.56 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2015 | $8,387,000 | +130.9% | 48,531 | +53.5% | 0.04% | +126.3% |
Q4 2014 | $3,633,000 | +4.2% | 31,611 | +41.7% | 0.02% | +11.8% |
Q3 2014 | $3,485,000 | -59.4% | 22,306 | -68.0% | 0.02% | -59.5% |
Q2 2014 | $8,593,000 | -19.4% | 69,666 | -32.3% | 0.04% | -16.0% |
Q1 2014 | $10,658,000 | +172.4% | 102,866 | +136.4% | 0.05% | +177.8% |
Q4 2013 | $3,913,000 | +314.1% | 43,508 | +208.0% | 0.02% | +260.0% |
Q3 2013 | $945,000 | +1.1% | 14,128 | 0.0% | 0.01% | 0.0% |
Q2 2013 | $935,000 | – | 14,128 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Verition Fund Management LLC | 2,787,800 | $481,760,000 | 55.98% |
Brenner West Capital Advisors | 1,800,000 | $311,058,000 | 28.01% |
FNY Managed Accounts LLC | 180,357 | $31,167,493,000 | 25.70% |
Twin Securities, Inc. | 1,189,192 | $205,505,000 | 24.16% |
FIRST NEW YORK SECURITIES LLC /NY | 98,099 | $16,952,488,000 | 16.70% |
HARVEST MANAGEMENT LLC | 77,500 | $13,393,000 | 14.40% |
Tyrus Capital S.A.M. | 687,800 | $118,859,000 | 13.24% |
BARDIN HILL MANAGEMENT PARTNERS LP | 472,550 | $81,661,000 | 11.65% |
ARGENTIERE CAPITAL AG | 151,500 | $26,181,000 | 10.81% |
Sachem Head Capital | 725,000 | $125,425,000 | 8.31% |